María Isabel
Álvarez Díaz
Profesor/a Asociado/a
Publicaciones (31) Publicaciones de María Isabel Álvarez Díaz
2022
-
The relationships between neuroglial alterations and neuronal changes in Alzheimer’s disease, and the related controversies I: Gliopathogenesis and glioprotection
Journal of Central Nervous System Disease, Vol. 14
-
The relationships between neuroglial and neuronal changes in Alzheimer’s disease, and the related controversies II: gliotherapies and multimodal therapy
Journal of Central Nervous System Disease, Vol. 14
2021
-
Reflections on cerebellar neuropathology in classical scrapie
Biomolecules, Vol. 11, Núm. 5
2016
-
Brain local and regional neuroglial alterations in alzheimer´s disease: Cell types, responses and implications
Current Alzheimer Research, Vol. 13, Núm. 4, pp. 321-342
-
Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in alzheimer's disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?
Current Alzheimer Research, Vol. 13, Núm. 4, pp. 403-412
2015
2014
-
Variability in the effects of nicotine on different regions of the brain: Changes in the concentration of superoxide dismutase isoforms
Central Nervous System Agents in Medicinal Chemistry, Vol. 14, Núm. 1, pp. 10-22
-
¿Existe la enfermedad de Alzheimer en todos los primates? Patología Alzheimer en primates no humanos y sus implicaciones fisiopatológicas (II)
Neurologia
2012
-
Alzheimer pathology in non-human primates and its pathophysiological implications
Primates: Classification, Evolution and Behavior (Nova Science Publishers, Inc.), pp. 71-110
-
Changes induced by natural scrapie in the calretinin-immunopositive cells and fibres of the sheep cerebellar cortex
Cerebellum
-
¿Existe la enfermedad de Alzheimer en todos los primates? Afección de Alzheimer en primates no humanos y sus implicaciones fisiopatológicas (I)
Neurologia
2011
-
Lesion-induced vertebrate models of Alzheimer dementia
Neuromethods, Vol. 48, pp. 295-345
2010
-
Diversity and variability of the effects of nicotine on different cortical regions of the brain. Therapeutic and toxicological implications
Central Nervous System Agents in Medicinal Chemistry, Vol. 10, Núm. 3, pp. 180-206
-
Multiple neuronal and glial mechanisms can be involved in the response to the activation of nicotinic receptors
Horizons in Neuroscience Research (Nova Science Publishers, Inc.), pp. 225-256
2008
-
Calretinin-immunopositive cells and fibers in the cerebellar cortex of normal sheep
Cerebellum, Vol. 7, Núm. 3, pp. 417-429
-
Immunohistochemical increase in cyclooxygenase-2 without apoptosis in different brain areas of subchronic nicotine- and D-amphetamine-treated rats
Journal of Neural Transmission, Vol. 115, Núm. 8, pp. 1093-1108
2006
-
Alteraciones de los fenómenos de neuroplasticidad en las enfermedades de Alzheimer y Creutzfeldt-Jakob. Interrelaciones con fenómenos involutivos
Mapfre Medicina, Vol. 17, Núm. 4, pp. 236-249
2004
-
Lesions and dysfunctions of the nucleus basalis as Alzheimer's disease models: general and critical overview and analysis of the long-term changes in several excitotoxic models.
Current Alzheimer research, Vol. 1, Núm. 3, pp. 189-214
2003
-
Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex
Journal of Neuroscience Research, Vol. 73, Núm. 5, pp. 708-716
2001
-
Histochemical study of acute and chronic intraperitoneal nicotine effects on several glycolytic and krebs cycle dehydrogenase activities in the frontoparietal cortex and subcortical nuclei of the rat brain
Journal of Neuroscience Research, Vol. 64, Núm. 6, pp. 626-635